IL37 and newborn respiratory distress syndrome: Though largely undescribed in early life, IL-37 has been shown to be beneficial in an animal model of neonatal respiratory distress syndrome (RDS) [173]; pre-treatment with 1 μg of recombinant human IL-37 ameliorated pathological changes [173] induced at P6 old mice injected i.p. with 10 mg/kg LPS.